Sabra Health Care REIT, Inc. (SBRA)
NASDAQ: SBRA · Real-Time Price · USD
18.53
-0.10 (-0.54%)
At close: Aug 13, 2025, 4:00 PM
18.52
-0.01 (-0.05%)
After-hours: Aug 13, 2025, 6:27 PM EDT
Sabra Health Care REIT Stock Forecast
Stock Price Forecast
According to 7 professional analysts, the 12-month price target for Sabra Health Care REIT stock ranges from a low of $18 to a high of $22. The average analyst price target of $20 forecasts a 7.93% increase in the stock price over the next year.
Price Target: $20.00 (+7.93%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Sabra Health Care REIT stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JMP Securities | JMP Securities | Buy Maintains $20 → $22 | Buy | Maintains | $20 → $22 | +18.73% | Aug 6, 2025 |
| Scotiabank | Scotiabank | Hold Maintains $19 → $20 | Hold | Maintains | $19 → $20 | +7.93% | Jun 23, 2025 |
| Scotiabank | Scotiabank | Hold Maintains $18 → $19 | Hold | Maintains | $18 → $19 | +2.54% | May 12, 2025 |
| Truist Securities | Truist Securities | Hold Maintains $17 → $18 | Hold | Maintains | $17 → $18 | -2.86% | Mar 18, 2025 |
| Citizens Capital Markets | Citizens Capital Markets | Buy Reiterates $20 | Buy | Reiterates | $20 | +7.93% | Feb 21, 2025 |
Financial Forecast
Revenue This Year
746.62M
from 702.64M
Increased by 6.26%
Revenue Next Year
800.10M
from 746.62M
Increased by 7.16%
EPS This Year
0.72
from 0.54
Increased by 33.17%
EPS Next Year
0.78
from 0.72
Increased by 8.98%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 821.0M | 992.7M | 1.1B | ||
| Avg | 746.6M | 800.1M | 889.4M | ||
| Low | 692.3M | 716.3M | 734.5M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 16.8% | 33.0% | 43.2% | ||
| Avg | 6.3% | 7.2% | 11.2% | ||
| Low | -1.5% | -4.1% | -8.2% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 0.80 | 0.88 | 0.88 |
| Avg | 0.72 | 0.78 | 0.82 |
| Low | 0.67 | 0.72 | 0.74 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 47.8% | 22.7% | 12.5% |
| Avg | 33.2% | 9.0% | 4.6% |
| Low | 23.4% | -0.5% | -6.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.